Advertisement

Most Recent

image: Opinion: Public Data, Private Concerns

Opinion: Public Data, Private Concerns

By | May 20, 2015

Research participants aren’t always clear on open data policies when consenting to studies.

0 Comments

image: Opinion: Upgrading Cancer Prevention

Opinion: Upgrading Cancer Prevention

By | April 1, 2015

Preemptive detection and intervention will be key to easing the growing burden of cancer, particularly in developing countries.

1 Comment

image: Opinion: <em>Star Trek</em> Medicine

Opinion: Star Trek Medicine

By | November 6, 2014

An apology for basic research

2 Comments

image: Opinion: Separate Training from Research Budgets

Opinion: Separate Training from Research Budgets

By | October 7, 2014

In order to make the most of biomedical research funding and to better support trainees, institutions should recognize postdocs as employees.

2 Comments

image: Opinion: #IceBucketChallenge, Investing Well

Opinion: #IceBucketChallenge, Investing Well

By | September 10, 2014

Hundreds of thousands participated in the ALS campaign that went viral, but how are they supposed to decide where to donate?

4 Comments

image: Opinion: The Murky World of Medical Ethics

Opinion: The Murky World of Medical Ethics

By | August 7, 2014

Why are researchers still denying some study participants potentially life-saving therapies?

0 Comments

image: Opinion: Thwarting Medical Tourism

Opinion: Thwarting Medical Tourism

By | June 17, 2014

It’s time to take a strong stance against unregistered cellular therapies, which can undermine legitimate research efforts.

0 Comments

image: Opinion: Pairing Discovery with Regulatory Rigor

Opinion: Pairing Discovery with Regulatory Rigor

By | May 13, 2014

To move cell-based therapies into the clinic, academic researchers may benefit by consulting researchers outside of academia and the biopharma industry.

0 Comments

image: Opinion: Overcoming Cancer’s Complexities

Opinion: Overcoming Cancer’s Complexities

By , , and | April 11, 2014

Considering “targeted therapeutics” in the face of intra-patient heterogeneity. 

2 Comments

image: Opinion: Translational Biotechnology

Opinion: Translational Biotechnology

By | February 17, 2014

Regulators must consider both the promise and potential pitfalls of new technologies when determining whether to move them into clinical trials.

0 Comments

Advertisement

Popular Now

  1. Most Earth-like Planet Found
  2. AAAAA Is for Arrested Translation
  3. Four-legged Snake Fossil Found
  4. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

Advertisement
Advertisement